+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice

Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice

Proceedings of the National Academy of Sciences of the United States of America 85(19): 7404-7407

We have evaluated the effect of neonatal administration of mouse prolactin (PRL) antiserum on the developmental expression of T- and B-lymphocytes in the thymus and spleen of female BALB/c mice. Newborn female mice were injected subcutaneously with a 50-microliters aliquot of PRL antiserum or normal rabbit serum on days 1, 2, and 3. On neonatal day 5, the PRL antiserum-treated group had a significantly (P less than 0.05) increased population of cells in the thymus and the spleen that were positive for Thy-1.2 and for L3T4. Increases in Thy-1.2- and L3T4-positive cells in the thymus were detectable also on days 8 and 14 in mice that received the PRL antiserum and in mice injected with bromocriptine, a dopamine agonist that inhibits PRL release from the anterior pituitary. On neonatal days 21, 28, and 32, there were no significant differences in the percentage of cells positive for Thy-1.2, Ly-2 (formerly Lyt-2), or L3T4 antigens in the thymus. However, there were significant increases in the percentage of Thy-1.2- and L3T4-positive spleen cells in the bromocriptine-treated group at all times monitored and in the PRL antiserum-treated group except on day 14. In addition, the percentage of splenocytes that were positive for IgG was significantly increased in the PRL antiserum-treatment group on days 8-28, although not on neonatal day 32. Of tissues known to contain PRL receptors, neonatal administration of PRL antiserum or bromocriptine resulted in a significant alteration in the wet weight of spleen and liver, with no significant effect in thymus, heart, and kidney. Pituitary implants also resulted in a significant increase in both concanavalin A- and lipopolysaccharide-stimulated thymidine incorporation into murine splenic lymphocytes prepared from 45-day-old female mice. These data extend the role of PRL as an immunomodulator of adult lymphocyte function to a role in the developmental expression of T- and B-lymphocyte populations in the thymus and spleen of mice.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 040780321

Download citation: RISBibTeXText

PMID: 3262874

DOI: 10.2307/32141

Related references

Long-term effects of neonatal hormonal treatments on plasma prolactin levels in female BALB/cfC3H and BALB/c mice. Cancer Research 38(4): 942-945, 1978

Autoreactive antibodies in thymus and spleen of neonatal and young adult BALB/c mice: influence of prenatal tolerization. Scandinavian Journal of Immunology 33(1): 25-36, 1991

Autoreactive b cells in thymus and spleen of neonatal and young adult balb c mice influence of prenatal tolerization. Immunobiology 181(2-3): 226-227, 1990

Carcinogenesis induced by the neonatal administration of 5-bromo-2'-deoxyuridine and subsequent exposure to estradiol benzoate in female BALB/c mice. Voprosy Onkologii 38(3): 320-327, 1992

Antigenic and chromosomal changes in thymus and spleen of Balb/Mo mice during leukemogenesis. Leukemia Research 6(3): 413-419, 1982

Didemnin b alters the specific binding of prolactin to human lymphocytes and decreases the circulating level of prolactin in mice. Federation Proceedings 44(3): 634, 1985

Long-term effects of neonatal administration of estrogen and progesterone, alone or in combination, on male BALB/c and BALB/cfC3H mice. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 165(1): 17-25, 1980

T and B lymphocyte populations of the spleen and thymus in normal and immunosuppressed BALB/c mice. Cellular Immunology 40(1): 79-90, 1978

Effects of neonatal inoculation of thymus antiserum on growth of sarcoma 180 in mice. Texas Reports on Biology and Medicine 23(4): 705-714, 1965

Equal distribution of T-lymphocyte subpopulations in thymus and spleen cells of NZB and BALB/c mice. Rheumatology International 4(1): 31-34, 1984

Decrease in adenylate cyclase activity in spleen T- and B-lymphocytes and thymus T-lymphocytes in CBA mice treated with levamisole. Ukrainskii Biokhimicheskii Zhurnal 60(3): 89-91, 1988

28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in PFOS-induced immunotoxicity?. Toxicology 267(1-3): 132-139, 2010

Effect of neonatal administration of prolactin on pituitary secretion of prolactin and gonadotrophins in adult female rats. Journal of Endocrinology 59(2): 377-378, 1973

The pattern of lymphocytes in the thymus and spleen after labeling with 3H-thymidine and 3H-deoxycytidine. Virchows Archiv. B Cell Pathology 28(3): 287-299, 1978

Modulation of dietary fat on the toxicological effects in thymus and spleen in BALB/c mice exposed to perfluorooctane sulfonate. Toxicology Letters 204(2-3): 174-182, 2011